Direkt zum Inhalt

Aus der ZeitschriftLSR 3/2021 | S. 125–136Es folgt Seite №125

Due Diligence in Life Science-Transaktionen

Eine Übersicht über pharma- und biotech-spezifische Besonderheiten

Keywords:
Mergers & Acquisitions, Due Diligence, Gesellschaftsrecht

Abstract

The life science industry is known for its lively M&A activities and this is not likely to change in the near future. Due diligence is an important part of this and an M&A process would be unthinkable without it. For liability reasons, the board of directors and management do well to conduct a thorough due diligence in any case…
[…]